Efficacy and safety of propranolol in the treatment of parotid hemangioma

Cutaneous and Ocular Toxicology

Volumn 30, Issue 3, 2011, Pages 245-248

  Morais, Paulo ^a   Magina, Sofia ^a   Mateus, Mário ^a   Trindade, Eunice ^a   Jesus, José Miguel ^a   Azevedo, Filomena ^a  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

hepatic hemangioendothelioma; infantile hemangioma; parotid hemangioma; Propranolol

Indexed keywords

PREDNISOLONE; PROPRANOLOL;

ABSENCE OF SIDE EFFECTS; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; FEMALE; HEMANGIOENDOTHELIOMA; HUMAN; HYPERTENSION; INFANT; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROTID GLAND TUMOR; TUMOR RECURRENCE;

ADRENERGIC BETA-ANTAGONISTS; FEMALE; HEMANGIOENDOTHELIOMA; HEMANGIOMA; HUMANS; INFANT; LIVER NEOPLASMS; MAGNETIC RESONANCE ANGIOGRAPHY; NEOPLASMS, SECOND PRIMARY; PAROTID NEOPLASMS; PROPRANOLOL;

EID: 80051499940     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2011.554483     Document Type: Article

References (14)

1. Greene AK, Rogers GF, Mulliken JB. Management of parotid hemangioma in 100 children. Plast Reconstr Surg 2004;113:53-60. (Pubitemid 39202007)
2. Brandling-Bennett HA, Metry DW, Baselga E, Lucky AW, Adams DM, Cordisco MR et al. Infantile hemangiomas with unusually prolonged growth phase: A case series. Arch Dermatol 2008;144:1632-1637.
3. George ME, Sharma V, Jacobson J, Simon S, Nopper AJ. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol 2004;140:963-969. (Pubitemid 39062647)
4. Léauté-Labréze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-2651. (Pubitemid 351831393)
5. Drugs.com. Propranolol Hydrochloride. http://www.drugs. com/monograph/propranolol-hydrochloride.html. Accessed December 8, 2010.
6. Guimarães S., Sistema adrenérgico. In: Terapěutica medicamentosa e suas bases farmacológicas, 4th ed. Osswald W, Guimarães S, eds. Porto Editora, Lda, Porto, 2001, pp. 293-334.
7. Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: Insights into the molecular mechanisms of action. Br J Dermatol 2010;163:269-274.
8. Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med 2008;359:2846.
9. Holland KE, Frieden IJ, Frommelt PC, Mancini AJ, Wyatt D, Drolet BA. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol 2010;146:775-778.
10. Sans V, de la Roque ED, Berge J, Grenier N, Boralevi F, Mazereeuw-Hautier J et al. Propranolol for severe infantile hemangiomas: Follow-up report. Pediatrics 2009;124:e423-e431.
11. Chen CC, Kong MS, Yang CP, Hung IJ. Hepatic hemangioendothelioma in children: Analysis of thirteen cases. Acta Paediatr Taiwan 2003;44:8-13.
12. Ganguly R, Mukherjee A. Infantile hemangioendothelioma: A case report and discussion. Pathol Res Pract 2010;206:53-58.
13. Liu XJ, Qin ZP, Tai MZ, Li KL, Ge CX. [Treatment of infantile parotid hemangioma with propranolol]. Zhonghua Kou Qiang Yi Xue Za Zhi 2010;45:292-294.
14. Sarialioglu F, Erbay A, Demir S. Response of infantile hepatic hemangioma to propranolol resistant to high-dose methylprednisolone and interferon-a therapy. Pediatr Blood Cancer 2010;55:1433-1434.